SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $23,000 | -11.5% | 88,669 | +144.5% | 0.00% | +50.0% |
| Q3 2019 | $26,000 | +52.9% | 36,266 | +56.4% | 0.00% | +100.0% |
| Q2 2019 | $17,000 | -83.2% | 23,184 | -37.5% | 0.00% | -80.0% |
| Q1 2018 | $101,000 | +405.0% | 37,117 | +267.7% | 0.01% | +400.0% |
| Q3 2017 | $20,000 | – | 10,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,134,926 | $3,375,000 | 3.69% |
| Aisling Capital Management LP | 10,100,000 | $4,190,000 | 1.82% |
| Samsara BioCapital, LLC | 5,938,215 | $2,464,000 | 1.42% |
| Corriente Advisors, LLC | 3,021,692 | $1,254,000 | 1.35% |
| MPM BioImpact LLC | 2,809,912 | $1,166,000 | 0.71% |
| Burrage Capital Management LLC | 682,586 | $280,000 | 0.28% |
| Avidity Partners Management LP | 4,310,000 | $1,788,000 | 0.25% |
| BVF INC/IL | 6,194,925 | $2,570,000 | 0.24% |
| Nantahala Capital Management | 9,566,844 | $3,969,000 | 0.15% |
| Worth Venture Partners, LLC | 362,330 | $150,000 | 0.09% |